Adherence to anticoagulation with atrial fibrillation is suboptimal and can lead to an increased risk of stroke. With this feasibility study, we want to evaluate if and under what circumstances MEMS can be used in real-life by community pharmacists to identify possible non-adherence.
Adherence to medication in chronic diseases is suboptimal. There are several validated methods and tools to identify possible non-adherence. The Medication Event Monitoring System (MEMS) is an electronic tool that allows to identify possible non-adherence and was originally developed for clinical trials.
To evaluate if and under what circumstances its possible to implement MEMS in a real-life setting, using DOAC as an example.
Contact: Dr. PharmD Sara Desmaele (firstname.lastname@example.org)